| Name | Title | Contact Details |
|---|
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.
Oxford Pharmaceutical Resources is a Totowa, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
B and B Medical Technologies Inc is a Loomis, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Golden Helix is a Bozeman, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MBF Capital Corporation is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.